| Target Price | CN¥25.19 |
| Price | CN¥19.40 |
| Potential |
29.87%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Guangzhou Baiyunshan Pharm-h 2027 .
The average Guangzhou Baiyunshan Pharm-h target price is CN¥25.19.
This is
29.87%
register free of charge
CN¥35.70
84.02%
register free of charge
CN¥15.55
19.82%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Guangzhou Baiyunshan Pharm-h to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Guangzhou Baiyunshan Pharm-h stock has an average upside potential 2027 of
29.87%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | 77.66 | 80.07 |
| 3.55% | 3.10% | |
| EBITDA Margin | 5.12% | 6.42% |
| 10.76% | 25.49% | |
| Net Margin | 3.84% | 3.66% |
| 1.60% | 4.72% |
4 Analysts have issued a sales forecast Guangzhou Baiyunshan Pharm-h 2026 . The average Guangzhou Baiyunshan Pharm-h sales estimate is
This results in the following potential growth metrics:
4 Guangzhou Baiyunshan Pharm-h Analysts have issued a net profit forecast 2026. The average Guangzhou Baiyunshan Pharm-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | 1.84 | 1.80 |
| 5.75% | 2.17% | |
| P/E | 10.78 | |
| EV/Sales | 0.45 |
4 Analysts have issued a Guangzhou Baiyunshan Pharm-h forecast for earnings per share. The average Guangzhou Baiyunshan Pharm-h EPS is
This results in the following potential growth metrics and future valuations:
Guangzhou Baiyunshan Pharm-h...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


